Bicalutamide binds to androgen receptors on prostate cancer cells, preventing androgens from interacting with these receptors. By doing so, it inhibits the growth and spread of cancer cells that rely on androgens for their proliferation. This mechanism of action makes bicalutamide particularly useful in treating advanced prostate cancer.
